Literature DB >> 1624160

Evolution of hereditary non-polyposis colorectal cancer.

J R Jass1, S M Stewart.   

Abstract

The prevalence of colorectal adenoma in 23 affected patients with hereditary non-polyposis colorectal cancer (HNPCC) was compared with that in an age matched forensic autopsy population. The mean ages at diagnosis of colorectal cancer in men (13) and women (10) were 39 and 37 years respectively. In HNPCC patients who presented below the age of 50 years, at least one adenoma was found in 3 of 10 (30%) men and in 4 of 9 (44%) women. In the age matched autopsy specimens of large bowel, a solitary adenoma was found in 2/42 (5%) men (p = 0.015) and 1/21 (5%) women (p = 0.0075). Of the 11 adenomas from HNPCC patients, nine were greater than 1 cm and six showed a pure villous architecture. Contiguous adenocarcinoma was observed with six adenomas. Adenomas do not occur in large numbers in HNPCC, but develop at a young age, attain a large size, often show a villous configuration, and are more prone to malignant conversion than sporadic adenomas.

Entities:  

Mesh:

Year:  1992        PMID: 1624160      PMCID: PMC1379336          DOI: 10.1136/gut.33.6.783

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  27 in total

1.  Multiple carcinomas of the large intestine: a review of the literature and a study of 261 cases.

Authors:  C G MOERTEL; J A BARGEN; M B DOCKERTY
Journal:  Gastroenterology       Date:  1958-01       Impact factor: 22.682

2.  Heredity and adenocarcinoma of the colon.

Authors:  H T Lynch; A J Krush
Journal:  Gastroenterology       Date:  1967-10       Impact factor: 22.682

3.  Colonoscopic screening of asymptomatic patients with a family history of colon cancer.

Authors:  J W Baker; J B Gathright; A E Timmcke; T C Hicks; B T Ferrari; J E Ray
Journal:  Dis Colon Rectum       Date:  1990-11       Impact factor: 4.585

4.  Family studies in cancer of the colon and rectum.

Authors:  E Lovett
Journal:  Br J Surg       Date:  1976-01       Impact factor: 6.939

5.  Adenocarcinoma of the small bowel in lynch syndrome II.

Authors:  H T Lynch; T C Smyrk; P M Lynch; S J Lanspa; B M Boman; J Ens; J F Lynch; P Strayhorn; T Carmody; G Cristofaro
Journal:  Cancer       Date:  1989-11-15       Impact factor: 6.860

6.  Hereditary nonpolyposis colorectal cancer (Lynch syndromes I and II). II. Biomarker studies.

Authors:  H T Lynch; G S Schuelke; W J Kimberling; W A Albano; J F Lynch; K A Biscone; M L Lipkin; E E Deschner; Y B Mikol; A A Sandberg
Journal:  Cancer       Date:  1985-08-15       Impact factor: 6.860

7.  Family incidence of carcinoma of the colon and rectum in north-east Scotland.

Authors:  J L Duncan; J Kyle
Journal:  Gut       Date:  1982-02       Impact factor: 23.059

8.  Colonoscopy in patients with a primary family history of colon cancer.

Authors:  J C McConnell; J S Nizin; M S Slade
Journal:  Dis Colon Rectum       Date:  1990-02       Impact factor: 4.585

9.  A family with a high incidence of cancer.

Authors:  C B Innes
Journal:  N Z Med J       Date:  1978-04-26

10.  Subsite distribution and incidence of colorectal cancer in New Zealand, 1974-1983.

Authors:  J R Jass
Journal:  Dis Colon Rectum       Date:  1991-01       Impact factor: 4.585

View more
  42 in total

Review 1.  Serrated adenoma of the colorectum: a lesion with teeth.

Authors:  Jeremy R Jass
Journal:  Am J Pathol       Date:  2003-03       Impact factor: 4.307

2.  Genetic reconstruction of individual colorectal tumor histories.

Authors:  J L Tsao; Y Yatabe; R Salovaara; H J Järvinen; J P Mecklin; L A Aaltonen; S Tavaré; D Shibata
Journal:  Proc Natl Acad Sci U S A       Date:  2000-02-01       Impact factor: 11.205

3.  Microsatellite instability in adenomas as a marker for hereditary nonpolyposis colorectal cancer.

Authors:  A Loukola; R Salovaara; P Kristo; A L Moisio; H Kääriäinen; H Ahtola; M Eskelinen; N Härkönen; R Julkunen; E Kangas; S Ojala; J Tulikoura; E Valkamo; H Järvinen; J P Mecklin; A de la Chapelle; L A Aaltonen
Journal:  Am J Pathol       Date:  1999-12       Impact factor: 4.307

4.  Host susceptibility to cancer progression.

Authors:  S A Narod
Journal:  Am J Hum Genet       Date:  1998-07       Impact factor: 11.025

5.  The genotype of the transporter associated with antigen processing gene affects susceptibility to colorectal cancer in Japanese.

Authors:  Takenori Yamauchi; Shouhei Takeuchi; Naoki Maehara; Yoshiki Kuroda
Journal:  Environ Health Prev Med       Date:  2014-05-07       Impact factor: 3.674

6.  Telomerase activity is commonly detected in hereditary nonpolyposis colorectal cancers.

Authors:  Z H Li; R Salovaara; L A Aaltonen; D Shibata
Journal:  Am J Pathol       Date:  1996-04       Impact factor: 4.307

7.  Hereditary nonpolyposis colon cancer: analysis of linkage to 2p15-16 places the COCA1 locus telomeric to D2S123 and reveals genetic heterogeneity in seven Canadian families.

Authors:  R C Green; S A Narod; J Morasse; T L Young; J Cox; G W Fitzgerald; P Tonin; O Ginsburg; S Miller; S Jothy
Journal:  Am J Hum Genet       Date:  1994-06       Impact factor: 11.025

8.  Hereditary colorectal cancer in china.

Authors:  Zheng Shu; Huang Yanqin; Yuan Ying
Journal:  Hered Cancer Clin Pract       Date:  2005-11-15       Impact factor: 2.857

Review 9.  Current hypotheses on how microsatellite instability leads to enhanced survival of Lynch Syndrome patients.

Authors:  Kristen M Drescher; Poonam Sharma; Henry T Lynch
Journal:  Clin Dev Immunol       Date:  2010-06-10

10.  Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2020 for the Clinical Practice of Hereditary Colorectal Cancer.

Authors:  Naohiro Tomita; Hideyuki Ishida; Kohji Tanakaya; Tatsuro Yamaguchi; Kensuke Kumamoto; Toshiaki Tanaka; Takao Hinoi; Yasuyuki Miyakura; Hirotoshi Hasegawa; Tetsuji Takayama; Hideki Ishikawa; Takeshi Nakajima; Akiko Chino; Hideki Shimodaira; Akira Hirasawa; Yoshiko Nakayama; Shigeki Sekine; Kazuo Tamura; Kiwamu Akagi; Yuko Kawasaki; Hirotoshi Kobayashi; Masami Arai; Michio Itabashi; Yojiro Hashiguchi; Kenichi Sugihara
Journal:  Int J Clin Oncol       Date:  2021-06-29       Impact factor: 3.402

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.